Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

Presentation TCT 2023

Ongoing Trials in CTO PCI: Ischemia-CTO, Co-CTO, Invest-CTO, STAR

Presenter: Anja Oksnes

October 26, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

TCT 550: Update on the DEEPER REVEAL IDE Trial: the Bare Temporary Spur Stent System for Critical Lismb Ischemia

Presenter: Mahmood Razavi

October 25, 2023

Presentation TCT 2023

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

Presenter: Gabor Toth

October 25, 2023

Presentation TCT 2023

TCT 627: Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data

Presenter: Daniel Snyder

October 24, 2023

News Conference News TCT 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Todd Neale

October 23, 2023

Advertisement

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Ongoing Trials in CTO PCI: Ischemia-CTO, Co-CTO, Invest-CTO, STAR

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

TCT 550: Update on the DEEPER REVEAL IDE Trial: the Bare Temporary Spur Stent System for Critical Lismb Ischemia

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

TCT 627: Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content